Severe Legionellosis Cases Admitted to Grenoble University Hospital, 2006-2011.
LEGIOGRE
Molecular Epidemiology of Legionellosis in Grenoble Region
1 other identifier
observational
82
0 countries
N/A
Brief Summary
The study aimed at further describing the epidemiological, clinical, diagnostic and prognostic features in legionellosis cases admitted to Grenoble University Hospital during the 2006-2011period. The investigators also tested lower respiratory samples collected from these patients during their routine medical care, using a number of molecular tools allowing determination of the involved Legionella species, the bacterial load, and the presence of antibiotic resistant mutants. Our primary goal was to define biological markers that could predict severity and outcome of infection in legionellosis cases requiring hospitalization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2009
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 22, 2016
CompletedFirst Posted
Study publicly available on registry
August 31, 2016
CompletedAugust 31, 2016
August 1, 2016
2.2 years
August 22, 2016
August 30, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Legionella DNA load in lower respiratory tract samples
Real-time polymerase chain reaction (qPCR) dosages in lower respiratory tract samples collected on a routine basis all over the hospitalization duration
through study completion, an average of 1 year
Secondary Outcomes (1)
Fluoroquinolones resistant gyrA mutants in lower respiratory tract samples
through study completion, an average of 1 year
Study Arms (1)
Severe legionellosis cases
Patients admitted to Grenoble University Hospital for severe legionellosis between 2006 and 2011.
Interventions
qPCR and high-throughput DNA sequencing testing of lower respiratory tract samples collected routinely in patients with severe legionellosis
Eligibility Criteria
82 unrelated legionellosis cases 64 males, 18 females mean age: 55 years, range: 27-97 years severe legionellosis requiring hospitalization
You may qualify if:
- age higher than 18 years
- proven legionellosis case (positive culture and/or PCR and/or urinary antigen test)
- severe case requiring hospitalization
You may not qualify if:
- age under 18 years
- pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Lower respiratory tract samples collected on a routine basis for microbiological analyses
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hélène Sabbah-Guillaume, Director
Direction of Research and Medical Innovation (DRCI)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pr. Max Maurin
Study Record Dates
First Submitted
August 22, 2016
First Posted
August 31, 2016
Study Start
September 1, 2009
Primary Completion
December 1, 2011
Study Completion
December 1, 2014
Last Updated
August 31, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will not share
Biological data are available at the bacteriology laboratory. Clinical data are available at the participating medical wards.